Jerry Karp

SELMA MEDICAL ASSOC INC

104 SELMA DR

Articles

Innovations in Treating Neuropathic Pain: Off-label Pharmaceuticals, Novel Orthotics, and Other New Approaches

March 22, 2005

Management of diabetic peripheral neuropathy (DPN) centers on proper footcare, offloading, and various orthotic devices to prevent the development of ulcers. Management trends, however, show that off-label use of some pharmaceutical agents is common and that these agents are proving beneficial in relieving the pain that can accompany DPN in up to 35% of patients. In addition, innovations in orthotic devices and new technologies for patient monitoring are being rolled out.